We are here to break the isolation so often felt by those with these rare diseases, and we would be delighted to welcome you into our 'family'.
The aim of our website is to direct you as quickly as possible to our support services and to information you can trust on multiple endocrine neoplasia (MEN) types 1, 2, and 3, medullary thyroid cancer (MTC), familial medullary thyroid cancer (FMTC), adrenal gland tumours (phaeochromocytomas), parathyroid hyperplasia, paragangliomas, familial isolated pituitary adenoma (FIPA) and succinate dehydrogenase (SDH) disorders.
AMEND's December newsletter was emailed to members this morning. Postal newsletter expected next week.
Learn about sporadic medullary thyroid cancer in this edition's My Story, as well as potential affects on membership from new data protection regulations. Meet Dave the office Beagle, and find out how we're planning to celebrate our 15th birthday in 2018.
Not a member? Click here to register now!
Come and join us for the weekend of 29th June when the AMEND team will be tackling the Yorkshire 3 Peaks Challenge!
This will surely be a memorable event with your fellow AMEND members and friends, all in aid of AMEND's Research Fund.
Get your walking boots on and visit our webpage for more information!
This event is organised by award-winning Discover Adventure. A minimum fundraising target applies.